Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 06, 2022 08:48 ET | Source: ORPHAZYME A/S

Updated Financial Calendar for 2022

Orphazyme A/S in restructuringCompany announcement No. 19/2022 www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, April 6, 2022 – Orphazyme A/S in restructuring...
April 06, 2022 04:00 ET | Source: ORPHAZYME A/S

Notice received from the Depositary to holders of ADSs regarding termination of Deposit Agreement

Orphazyme A/S in restructuringCompany announcementNo. 18/2022www.orphazyme.comCompany Registration No. 32266355 NOTICE TO HOLDERS OF AMERICAN DEPOSITARY SHARES (“ADSs”) EVIDENCED BYAMERICAN...
April 04, 2022 13:44 ET | Source: ORPHAZYME A/S

Correction: Proposal for a statutory restructuring plan

Orphazyme A/S in restructuringCompany announcementNo. 17/2022Inside information www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, April 4, 2022 – Orphazyme A/S in...
March 31, 2022 17:37 ET | Source: ORPHAZYME A/S

Voluntary delisting of ADSs has become effective

Orphazyme A/S in restructuringCompany announcementNo. 16/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 31, 2022 – Orphazyme A/S in restructuring (ORPHA.CO)...
March 31, 2022 12:00 ET | Source: ORPHAZYME A/S

Proposal for a statutory restructuring plan

Orphazyme A/S in restructuringCompany announcementNo. 15/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 31, 2022 – Orphazyme A/S in...
March 29, 2022 07:15 ET | Source: ORPHAZYME A/S

Updated Financial Calendar for 2022

Orphazyme A/S in restructuringCompany announcementNo. 14/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 29, 2022 – Orphazyme A/S in restructuring (ORPHA.CO; ORPH)...
March 22, 2022 06:54 ET | Source: ORPHAZYME A/S

Orphazyme announces withdrawal of European Marketing Authorisation Application for arimoclomol for the treatment of Niemann-Pick disease type C

Orphazyme A/SCompany announcementNo. 13/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Decision to withdraw the European Marketing Authorisation Application comes ahead of...
March 21, 2022 17:44 ET | Source: ORPHAZYME A/S

Orphazyme A/S has filed for voluntary delisting of ADSs

Orphazyme A/SCompany announcementNo. 12/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 21, 2022 – Orphazyme A/S (ORPHA.CO; ORPH) (“Orphazyme” or the “Company”), a...
March 18, 2022 06:40 ET | Source: ORPHAZYME A/S

Notice of in-court restructuring proceedings of Orphazyme A/S

Orphazyme A/SCompany announcementNo. 11/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 18, 2022 – Orphazyme A/S (ORPHA.CO; ORPH) (“Orphazyme” or the “Company”), a...
March 10, 2022 16:05 ET | Source: ORPHAZYME A/S

Commencement of in-court restructuring of Orphazyme A/S

Orphazyme A/SCompany announcementNo. 10/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Will institute a reduction of approximately 50% of current work forceIntends to...